Global Retirement Partners LLC Acquires 2,609 Shares of Cardinal Health, Inc. $CAH

Global Retirement Partners LLC boosted its stake in Cardinal Health, Inc. (NYSE:CAH) by 73.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,169 shares of the company’s stock after purchasing an additional 2,609 shares during the quarter. Global Retirement Partners LLC’s holdings in Cardinal Health were worth $1,268,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. Aventura Private Wealth LLC acquired a new position in Cardinal Health in the fourth quarter valued at about $25,000. Jones Financial Companies Lllp raised its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. JPL Wealth Management LLC acquired a new position in Cardinal Health in the third quarter valued at about $31,000. Turning Point Benefit Group Inc. acquired a new position in Cardinal Health in the third quarter valued at about $31,000. Finally, Cape Investment Advisory Inc. raised its stake in Cardinal Health by 61.1% in the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock valued at $33,000 after purchasing an additional 80 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.1%

Shares of NYSE CAH opened at $200.42 on Monday. The stock has a 50-day moving average price of $205.21 and a two-hundred day moving average price of $208.82. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60. The company has a market cap of $46.94 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.19 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 earnings per share. The firm’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s payout ratio is currently 31.19%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of analyst reports. Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. TD Cowen boosted their price target on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. JPMorgan Chase & Co. dropped their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Barclays boosted their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Finally, Zacks Research raised Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.